Dys-synchronous regulation of XPC and XPA in trigeminal ganglion neurons following cisplatin treatment cycles

Anticancer Research

Volumn 28, Issue 5 A, 2008, Pages 2637-2640

  Guthrie, O'Neil W ^a,b,c  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b University of Pittsburgh School of Medicine   (United States)

^c DUKE UNIVERSITY   (United States)

Author keywords

Cisplatin; Nucleotide excision repair; Trigeminal ganglion

Indexed keywords

CISPLATIN; XERODERMA PIGMENTOSUM GROUP A PROTEIN; XERODERMA PIGMENTOSUM GROUP C PROTEIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL SURVIVAL; CONTROLLED STUDY; DNA REPAIR; IMMUNOHISTOCHEMISTRY; IMMUNOLOCALIZATION; IN VITRO STUDY; NERVE CELL; NONHUMAN; PRIORITY JOURNAL; RAT; TRIGEMINUS GANGLION;

ANIMALS; CISPLATIN; DNA-BINDING PROTEINS; IMMUNOHISTOCHEMISTRY; RATS; RATS, INBRED F344; SENSORY RECEPTOR CELLS; TRIGEMINAL GANGLION; XERODERMA PIGMENTOSUM GROUP A PROTEIN;

EID: 55749101018     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Gordon M and Hollander S: Review of platinum anticancer compounds. Med 24: 209-265, 1993.
2. Weiss RB and Christian MC: New cisplatin analogues in development. Drugs 46: 360-377, 1993.
3. Giaccone G: Clinical perspectives on platinum resistance. Drugs 59(Suppl.4): 9-17, 2000.
4. Brock PR, Bellman SC, Yeomans EC, Pinkerton CR and Pritchard J: Cisplatin ototoxicity in children: a practical grading system. Med and Pediat Oncology 19: 295-300, 1991.
5. Dzagnidze A, Katsarava Z, Makhalova J, Liedert B, Yoon MS, Kaube H, Limmroth V and Thomale J: Repair capacity for platinum-DNA adducts determines the severity of cisplatin-induced peripheral neuropathy. J Neurosci 29: 9451-9457, 2007.
6. Bhana S, Hewer A, Phillips DH and Lloyd DR: P53-dependent global nucleotide excision repair of cisplatin-induced intrastrand cross links in human cells. Mutagenesis 23: 131-136, 2008.
7. Swinnen LJ, Rankin C, Carraway H, Albain KS, Townsend JJ, Budd GT, Kish JA, Rivkin SE and Blumenthal DT: A phase II study of cisplatin preceded by a 12-h continuous infusion of concurrent hydroxyurea and cytosine arabinoside (Ara-C) for adult patients with malignant gliomas (Southwest Oncology Group S9149). J Neurooncol 86: 353-358, 2008.
8. Stevens EV, Nishizuka S, Antony S, Reimers M, Varma S, Young L, Munson PJ, Weinstein JN, Kohn EC and Pommier Y: Predicting cisplatin and trabectedin drug sensitivity in ovarian and colon cancers. Mol Cancer Ther 7: 10-18, 2008.
9. Shuck SC, Short EA and Turchi JJ: Eukaryotic nucleotide excision repair: from understanding mechanisms to influencing biology. Cell Res 18: 64-72, 2008.
10. Hey T, Lipps G, Sugasawa K, Iwai S, Hanaoka F and Krauss G: The XPC-HR23B complex displays high affinity and specificity for damaged DNA in a true-equilibrium fluorescence assay. Biochemistry 41: 6583-6587, 2002.
11. Fousteri M and Mullenders LHF: Transcription-coupled nucleotide excision repair in mammalian cells: molecular mechanisms and biological effects. Cell Res 18: 73-84, 2008.
12. Tsodikov OV, Ivanov D, Orelli B, Staresincic L, Shoshani I, Oberman R, Schärer OD, Wagner G and Ellenberger T: Structural basis for the recruitment of ERCCI-XPF to nucleotide excision repair complexes by XPA. EMBO J 26: 4768-4776, 2007.
13. Köberle B, Roginskaya V and Wood RD: XPA protein as a limiting factor for nucleotide excision repair and UV sensitivity in human cells. DNA Repair 5: 641-648, 2006.
14. Costa RM A, Chigancas V, Galhardo RDS, Carvalho H and Menck CFM: The eukaryotic nucleotide excision repair pathway. Biochimie 85: 1083-1099, 2003.
15. Wu Y-H, Cheng Y-W, Chang JT, Wu T-C, Chen C-Y and Lee H: Reduced XPC messenger RNA level may predict a poor outcome of patients with nonsmall cell lung cancer. Cancer 110: 215-223, 2007.
16. Romanenko A, Morimura K, Wei M, Zaparin W, Vozianov A and Fukushima S: DNA damage repair in bladder urothelium after the Chernobyl accident in Ukraine. J Urol 168: 973-977, 2002.
17. Jaitovich-Groisman I, Benlimame N, Slagle BL, Perez MH, Alpert L, Song DJ, Fotouhi-Ardakani N, Galipeau J and Alaoui-Jamali MA: Transcriptional regulation of the TFIIH transcription repair complexes XPB and XPD by the hepatitis B virus x protein in liver cells and transgenic liver tissue. J Biol Chem 276: 14124-14132, 2001.
18. Theruvathu JA, Jaruga P, Dizdaroglu M and Brooks PJ: The oxidatively induced DNA lesions 8,5'-cyclo-2'-deoxyadenosine and 8-hydroxy-2'-deoxyadenosine are strongly resistant to acid-induced hydrolysis of the glycosidic bond. Mech Ageing Dev 128: 494-502, 2007.
19. Brooks PJ: The case for 8,5'-cyclopurine-2'-deoxynucleosides as endogenous DNA lesions that cause neurodegeneration in xeroderma pigmentosum. Neuroscience 145: 1407-1417, 2007.
20. Yamamoto A, Nakamura Y, Kobayashi N, Iwamoto T, Yoshioka A, Kuniyasu H, Kishimoto T and Mori T: Neurons and astrocytes exhibit lower activities of global genome nucleotide excision repair than do fibroblasts. DNA Repair (Amst) 6: 649-657, 2007.
21. van der Wees C, Jansen J, Vrieling H, van der Laarse A, Van Zeeland A and Mullenders L: Nucleotide excision repair in differentiated cells. Mutat Res 614: 16-23, 2007.
22. Sugimoto T, Takeyama A, Fujita M, Ichikawa H and Takano-Yamamoto T: Peripheral neuroglial death induced by cisplatin administration in newborn rats. NeuroReport 12: 137-140, 2001.